Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)

Market Cap	62.40B
Revenue (ttm)	267.12B
Net Income (ttm)	4.10B
Shares Out	3.70B
EPS (ttm)	1.10
PE Ratio	17.50
Forward PE	15.37
Dividend	0.41 (2.13%)
Ex-Dividend Date	Jul 22, 2024

Volume	5,994,248
Open	19.43
Previous Close	19.38
Day's Range	19.25 - 19.51
52-Week Range	15.36 - 20.23
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About Shanghai Pharmaceuticals Holding

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, syste...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 48,164
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 601607

Financial Performance

In 2023, 601607's revenue was 260.30 billion, an increase of 12.21% compared to the previous year's 231.98 billion. Earnings were 3.77 billion, a decrease of -32.92%.